Redcare Pharmacy rises on EBITDA beat, outlook lift

Redcare Pharmacy NV

01/08/2023 07:51

** Shares in Redcare Pharmacy  RDC.DE  are up 4% in early
Frankfurt trade after the online pharmacy beat Q2 EBITDA
estimates and raised 2023 sales and margin guidance
    ** Redcare reports Q2 adjusted EBITDA of 11.9 million euros 
($13.1 million), excluding MediService AG; this was above
consensus, according to a local trader
    ** The company sees non-prescription drug sales growth of
20-30%, up from 10-20%, and adj. EBITDA margin of 1.5%-3%, up
from 0.5%-2.5% previously
    ** "It was expected that Redcare would raise guidance with
final Q2 numbers but the margin lift seems a bit higher than
hoped for," the trader says

($1 = 0.9099 euros)

 (Reporting by Paolo Laudani)
 ((Paolo.laudani@thomsonreuters.com))